Mibelle Biochemistry successfully completed an asset deal with Mirexus, strengthening its active-ingredient portfolio.
WHO: Mirexus is a Canadian company that offers a sustainable plant-derived glycogen (phytoglycogen) called PhytoSpherix, for use in branded personal care products PhytoSpherix, EnerZea, Adveen, and Susttain.
Mibelle Biochemistry designs and develops unique, high-quality actives for the beauty, nutraceutical, and food industry based on naturally derived compounds and extensive scientific expertise. This is an independent business unit within the Mibelle Group founded in 1991 by Dr. Fred Zülli in Buchs, Switzerland.
WHY: The transaction strengthens Mibelle Biochemistry's active-ingredient portfolio and enhances its position as a developer and manufacturer of unique, high-quality active ingredients for the cosmetic and nutraceutical industry. The new assets also drive the company's sustainable innovation efforts by further aligning the portfolio with the rising demand for natural and sustainable ingredients.
IN THEIR OWN WORDS: "I am very excited about this asset deal, as we had been looking around for quite a while to find a perfect target, matching our philosophy 'inspired by nature—realized by science' and similarly fitting smoothly into our existing product portfolio," said Cornelia Schürch, Managing Director at Mibelle Biochemistry. "PhytoSpherix is finally fulfilling both requirements."
"All of us at Mirexus are thrilled to find the ideal home for our technology at Mibelle Biochemistry. The deep knowledge and capabilities of Mibelle will enable the growth of this technology beyond what Mirexus could do on its own. We look forward to seeing the continued expansion of our technology under Mibelle's experienced leadership," said Phil Whiting, President & CEO of Mirexus Biotechnologies Inc.
DETAILS:
